Anna Obenauf joins ADAPTMET to train the next generation of metastasis scientists

The Research Institute of Molecular Pathology (IMP) joins the EU-funded project ADAPTMET with eleven prestigious European institutes to train 15 young scientists in metastasis research over four years, with a funding of 4.4 million Euro.

Anna Obenauf, Senior Group Leader at the IMP, who is part of the ADAPTMET consortium.

Metastasis, the spread of cancer from its original site to other parts of the body, is responsible for approximately 90 percent of cancer-related deaths. As cancer cells colonise secondary environments, adaptation is crucial for their survival, making it one of the most important processes to dissect when studying cancer progression.

The European project ADAPTMET, coordinated by the Institute for Research in Biomedicine (IRB) Barcelona, aims to boost research on metastasis with a dual focus: deepening our understanding of metastatic cancers to develop innovative and effective treatment strategies; and training the next generation of scientists in metastasis research through a multidisciplinary and intersectoral programme.

Anna Obenauf, Senior Group Leader at the IMP, will head the research focused on understanding how the immune system interacts with early metastatic cancer cells, exploring why some evade immunity while others are eliminated.

Read the full story here.

Full news item by the IRB.